). An exception to this rule is nicotine, a drug which activation or depression in behavior are not influencing the measures used to hypothesize anxiolytic-like effects also increases arousal and wakefulness and produces anxiolytic-like, antistress effects. Long documented, and lend more credence to an antianxiety action of NPS. Further statistical analysis within a given animal model this paradox has been held as an example of how arousal and stress do not always follow a monophasic of anxiety also confirmed a loading on the anxiolytic measure. Obviously, small molecule compounds will be continuum. Nesbitt (1973) allowed smokers to smoke during a stressful experience (sessions where they rerequired to test this hypothesis in humans and to determine if there is any functional role for NPS in the arousal/ ceived painful shocks), and these smokers showed more arousal (increase in pulse rate) but reported less emotion anxiety domain. The anatomical localization of NPS also provides (more pain endurance, more shocks taken) than smokers that were not allowed to smoke but that simulated some intriguing links to long-hypothesized pontine roles in sleep, waking, and arousal. NPS is not localized within smoking. These early results were interpreted to support the Nesbitt paradox that is reported by smokers-that the locus coeruleus (LC). Neuropeptide S-expressing neurons do not produce norepinephrine, and locus coertheir physiological arousal is increased but they report uleus norepinephrine neurons do not contain NPS reissue of Neuron, Kanai et al. use affinity chromatograceptor mRNA. Indeed, there appears to be a cluster of phy and mass spectrometry to identify a large number NPS-expressing neurons in the pons that do not proof new factors that associate with kinesin, a molecular duce either norepinephrine or corticotropin-releasing motor, and employ siRNA technology to demonstrate factor but that are located in-between the locus coerutheir importance for RNA transport in neurons. leus (norepinephrine) and Barrington's nucleus (corticotropin-releasing factor). NPS cells located in the pons, Often times, cells concentrate certain proteins in particwhere they are most abundant, could be involved in an ular regions so that the metabolic events that they cataarousal projection from the pons to rostral areas of the lyze occur only locally. How they accomplish this task brain, including the cortex, amygdala, and thalamus, depends on the cell and the protein, but consider three where its cognate receptor is localized (see Figure 1) . general possibilities: make the protein everywhere but Thus, the peri-locus coeruleus NPS neuronal system destroy it where it is not needed, distribute mRNA encould be a novel and important component of a cortical coding the protein everywhere but translate it only loarousal system that has long been hypothesized to be cally, or transport the mRNA in a silent form to the place part of the reticular activating system (Moruzzi and Mawhere it is to be translated. The transport of silent mRNA goun, 1949).
would seem to be especially complicated, as it would In summary, the novel neuropeptide NPS has been require three sets of machinery: that needed for moving localized in the brain in areas that are relevant for arousal the cargo, for keeping the RNA silent while it is being and wakefulness and at the same time presents with a moved, and for activating the mRNA once it arrives at profile of an anxiolytic in animal models of anxiety. This its destination. In neurons, a variety of mRNAs are transcontrasts with its pontine neighbors norepinephrine (which ported into dendrites, quite possibly in a quiescent state; increases arousal but can have stress-like effects), hypothe products of these mRNAs, which are thought to be cretin/orexin A (which increases arousal and has little synthesized at or near activated synapses, may then stress-like effects but may have aversive effects), and modify synaptic plasticity ( 
